Tilray Brands, Inc. Convertible Debt, Current
Tilray Brands, Inc. (TLRY) had Convertible Debt, Current of $0 as of 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2026-07-28
- 2026-05-31: Convertible Debt, Current $0.00.
- 2026-02-28: Convertible Debt, Current $0.00.
- 2025-11-30: Convertible Debt, Current $0.00.
- 2025-08-31: Convertible Debt, Current $0.00.
| Period end | Convertible Debt, Current |
|---|---|
| 2026-05-31 | $0.00 10-K · filed 2026-07-28 |
| 2026-02-28 | $0.00 10-Q · filed 2026-04-01 |
| 2025-11-30 | $0.00 10-Q · filed 2026-01-08 |
| 2025-08-31 | $0.00 10-Q · filed 2025-10-09 |
| 2025-05-31 | $0.00 10-K · filed 2026-07-28 |
| 2025-02-28 | $0.00 10-Q · filed 2025-04-08 |
| 2024-12-31 | $0.00 10-Q · filed 2025-04-08 |
| 2024-11-30 | $0.00 10-Q · filed 2025-01-10 |
| 2024-08-31 | $0.00 10-Q · filed 2024-10-10 |
| 2024-05-31 | $330.00K 10-K · filed 2025-07-29 |
| 2024-02-29 | $83.35M 10-Q · filed 2024-04-09 |
| 2023-12-31 | $330.00K 10-Q · filed 2025-04-08 |
| 2023-11-30 | $128.40M 10-Q · filed 2024-01-09 |
| 2023-08-31 | $251.59M 10-Q · filed 2024-10-10 |
| 2023-05-31 | $174.38M 10-Q · filed 2024-10-10 |
| 2023-02-28 | $184.08M 10-Q · filed 2023-04-10 |
| 2022-11-30 | $181.51M 10-Q · filed 2023-01-09 |
| 2022-05-31 | $0.00 10-K · filed 2023-07-26 |
| 2022-03-31 | $0.00 10-Q · filed 2023-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |